港交所(00388.HK)料7月2日起提高恆生指數衍生產品持倉限額
港交所(00388.HK)宣佈,待獲監管批準後,暫定於7月2日起,提高在期交所交易的恆生指數、恆生中國企業指數及恆生科技指數期貨及期權產品的持倉限額。
恆生指數、恆生中國企業指數及恆生科技指數期貨及期權產品的持倉限額,將分別由1萬、1.2萬及2.1萬,增至1.5萬、2.5萬及3萬份。
是次上調反映了證監會於今年4月發佈諮詢總結後,對恆生衍生產品法定持倉限額提出的修改建議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.